Behavioral health company Acadia Healthcare (NASDAQ: ACHC) will be announcing earnings results this Wednesday morning. Here’s what you need to know.

Acadia Healthcare beat analysts’ revenue expectations last quarter, reporting revenues of $851.6 million, up 4.4% year on year. It was a slower quarter for the company, with a significant miss of analysts’ full-year EPS guidance estimates and full-year EBITDA guidance missing analysts’ expectations.

Is Acadia Healthcare a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, the market is expecting Acadia Healthcare’s revenue to grow 3.2% year on year, slowing from the 4.2% increase it recorded in the same quarter last year.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Acadia Healthcare has missed Wall Street’s revenue estimates multiple times over the last two years.

Looking at Acadia Healthcare’s peers in the healthcare providers & services segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Tenet Healthcare delivered year-on-year revenue growth of 9%, beating analysts’ expectations by 1.1%, and HCA Healthcare reported revenues up 6.7%, falling short of estimates by 1%. Tenet Healthcare traded up 20.3% following the results while HCA Healthcare was also up 4%.

Read our full analysis of Tenet Healthcare’s results here and HCA Healthcare’s results here.

The outlook for 2025 remains clouded by potential trade policy changes and corporate tax discussions, which could impact business confidence and growth. While some of the healthcare providers & services stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 3.5% on average over the last month. Acadia Healthcare is up 14.4% during the same time and is heading into earnings with an average analyst price target of $18.71 (compared to the current share price of $17.56).

Today’s young investors won’t have read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.